Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington; Multiple Sclerosis Center of Excellence-West, Veterans Administration Puget Sound, Seattle Division, Seattle, Washington.
University of Washington School of Medicine, Seattle, Washington.
Arch Phys Med Rehabil. 2021 Apr;102(4):694-701. doi: 10.1016/j.apmr.2020.09.385. Epub 2020 Oct 17.
To (1) describe depressive symptom severity and suicidal ideation (SI) in persons with progressive multiple sclerosis (MS); (2) compare depressive symptom severity and SI in persons with progressive MS and persons with relapsing-remitting multiple sclerosis (RRMS); and (3) identify common and unique risk factors for greater depressive symptom severity and SI in persons with progressive MS compared with individuals with RRMS.
Observational, cross-sectional survey study.
Community.
Adults with MS (N=573).
Not applicable.
The dependent variables were depression symptoms and any SI measured by the Patient Health Questionnaire-9. Comparisons between groups used t tests and chi-square analyses, and risk factors were tested by examining the interaction of MS subtype (progressive MS and RRMS) and each risk factor in multiple regression models with bootstrapping.
Persons with progressive MS did not differ from persons with RRMS in levels of depressive symptoms or SI. Both groups reported mild depressive symptoms and approximately 10% endorsed SI. Common risk factors for greater depressive symptom severity were younger age, greater disability, greater speech and swallowing problems, and lower household income. Common risk factors for SI were shorter disease duration, greater disability, and greater speech and swallowing problems.
In this sample, there were no group differences between persons with progressive MS and persons with RRMS in depressive symptom severity and SI. Although both groups reported mild depressive symptoms on average, nearly 1 in 4 persons met criteria for probable major depression, which underscores the importance of screening for and treating depressive disorders in all persons with MS.
(1)描述进展性多发性硬化症(MS)患者的抑郁症状严重程度和自杀意念(SI);(2)比较进展性 MS 患者和复发性缓解型多发性硬化症(RRMS)患者的抑郁症状严重程度和 SI;(3)确定进展性 MS 患者与 RRMS 患者相比,出现更严重的抑郁症状严重程度和 SI 的常见和独特的危险因素。
观察性、横断面调查研究。
社区。
多发性硬化症患者(N=573)。
不适用。
因变量为抑郁症状和患者健康问卷-9 测量的任何 SI。组间比较采用 t 检验和卡方分析,通过检查 MS 亚型(进展性 MS 和 RRMS)与每个风险因素在多元回归模型中的交互作用,并使用 bootstrap 进行风险因素检验。
进展性 MS 患者与 RRMS 患者在抑郁症状或 SI 水平上没有差异。两组均报告轻度抑郁症状,约 10%的人报告有 SI。抑郁症状严重程度更大的常见危险因素是年龄较小、残疾程度较大、言语和吞咽问题较多、家庭收入较低。SI 的常见危险因素是疾病持续时间较短、残疾程度较大以及言语和吞咽问题较多。
在本研究样本中,进展性 MS 患者和 RRMS 患者在抑郁症状严重程度和 SI 方面没有组间差异。尽管两组患者平均报告轻度抑郁症状,但近 1/4 的患者符合可能的重度抑郁症标准,这强调了在所有多发性硬化症患者中筛查和治疗抑郁障碍的重要性。